Lacaba, Jennifer L.

HRN: 15-67-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2024
BENZYL PENICILLIN 1MU (VIAL)
05/11/2024
05/11/2024
IM
1g
Every 3 Weeks
Rheumatic Heart Disease
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: